Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Preeti K. Sudheendra"'
Autor:
Kai C. C. Johnson, Ai Ni, Dionisia Quiroga, Ashley C. Pariser, Preeti K. Sudheendra, Nicole O. Williams, Sagar D. Sardesai, Mathew Cherian, Daniel G. Stover, Margaret Gatti-Mays, Bhuvaneswari Ramaswamy, Maryam Lustberg, Sachin Jhawar, Roman Skoracki, Robert Wesolowski
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract There is limited data regarding the added benefit of adjuvant systemic therapy in the management of small, node-negative, HER2+ breast cancer. In a multi-institutional retrospective analysis using the American Society of Clinical Oncology Ca
Externí odkaz:
https://doaj.org/article/fc9fb37c438d44728b8717088153f8ae
Autor:
Jasmine S. Sukumar, Sagar Sardesai, Andy Ni, Nicole Williams, Bhuvaneswari Ramaswamy, Robert Wesolowski, Mathew A. Cherian, Daniel Stover, Margaret Gatti-Mays, Ashley C. Pariser, Preeti K. Sudheendra, Mridula A. George, maryam lustberg
Publikováno v:
Cancer Research. 83:P1-02
Background: Approximately 10% of breast cancers (BC) are hormone receptor positive (HR+) and HER2 positive (HER2+). Despite treatment advances in the modern era of HER2 targeted therapies for early-stage disease, there remains a risk for late relapse
Autor:
Anna Juncker-Jensen, David Tallman, Harry Nunns, Heather Lefebvre, Karen Yamamoto, Katharine A. Collier, Mark Vater, Ava Strahan, Ava Willoughby, Olivia Bouchard, Madison Kingsbury, Mathew Cherian, Ashley C. Pariser, Preeti K. Sudheendra, Bhuvaneswari Ramaswamy, Margaret Gatti-Mays, Ainura Kyshtoobayeva, Zaibo Li, Daniel G. Stover
Publikováno v:
Cancer Research. 83:4639-4639
Background: Breast cancer is characterized by distinct molecular subtypes based on expression of estrogen and progesterone hormone receptors (ER and PR), and epidermal growth factor receptor 2 (HER2). To investigate presence and location of distinct
Autor:
Dionisia Quiroga, Michael Grimm, Julie Stephens, Kai Johnson, Nicole Williams, Preeti K. Sudheendra, Mathew A. Cherian, Daniel Stover, Ashley C. Pariser, Margaret Gatti-Mays, Robert Wesolowski, Jose G. Bazan, Sasha Beyer, Ko Un Park, Bridget Oppong, Bhuvaneswari Ramaswamy, Julia White, Sachin R. Jhawar, Sagar Sardesai
Publikováno v:
Cancer Research. 83:P4-02
Background: Hormone receptor (HR) low (1-10%) HER2-negative breast cancer (BC) is emerging as a distinct subtype with similarities in clinical outcomes to triple-negative BC. However, there is a lack of consensus on treatment recommendations for chem
Autor:
Johnson, Kai C. C., Ni, Ai, Quiroga, Dionisia, Pariser, Ashley C., Sudheendra, Preeti K., Williams, Nicole O., Sardesai, Sagar D., Cherian, Mathew, Stover, Daniel G., Gatti-Mays, Margaret, Ramaswamy, Bhuvaneswari, Lustberg, Maryam, Jhawar, Sachin, Skoracki, Roman, Wesolowski, Robert
Publikováno v:
NPJ Breast Cancer; 6/19/2024, Vol. 10 Issue 1, p1-8, 8p
Publikováno v:
Women's Health Weekly; 7/15/2024, p894-894, 1p